Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F3WR
|
|||
| Former ID |
DNC014825
|
|||
| Drug Name |
2-(3-methoxybenzylthio)-2-phenylacetic acid
|
|||
| Synonyms |
MLS003115376; 2-(3-methoxybenzylthio)-2-phenylacetic acid; CHEMBL493464; 7037-33-4; NSC268685; AC1L82IK; 2-[(3-methoxyphenyl)methylsulfanyl]-2-phenylacetic acid; DTXSID20313306; BDBM50253013; NSC-268685
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H16O3S
|
|||
| Canonical SMILES |
COC1=CC=CC(=C1)CSC(C2=CC=CC=C2)C(=O)O
|
|||
| InChI |
1S/C16H16O3S/c1-19-14-9-5-6-12(10-14)11-20-15(16(17)18)13-7-3-2-4-8-13/h2-10,15H,11H2,1H3,(H,17,18)
|
|||
| InChIKey |
DCWDBUYRVFMPPL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 7037-33-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hormone sensitive lipase (LIPE) | Target Info | Inhibitor | [1] |
| BioCyc | Triacylglycerol degradation | |||
| KEGG Pathway | cAMP signaling pathway | |||
| AMPK signaling pathway | ||||
| Insulin signaling pathway | ||||
| Panther Pathway | Triacylglycerol metabolism | |||
| Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
| WikiPathways | Insulin Signaling | |||
| Triacylglyceride Synthesis | ||||
| Lipid digestion, mobilization, and transport | ||||
| Adipogenesis | ||||
| Fatty Acid Beta Oxidation | ||||
| AMPK Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of n... J Med Chem. 2008 Oct 23;51(20):6478-94. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.